RNA-Sequencing-Based lncRNA Biomarker Profiling on Triple Negative Breast Cancer
DOI:
https://doi.org/10.30683/1929-2279.2021.10.01Keywords:
TNBC, long noncoding RNA (lncRNA), RNA-sequencing, ZEB1-AS1, TMEM254-AS1, LINC01087, LINC01122, LINC00856.Abstract
Abstract: Basal-like triple-negative breast cancer (TNBC) is highly heterogeneous and lack of effective molecular targets for therapy. In this study, we developed the lncRNA signatures of TNBC as molecular biomarkers. RNA-sequencing in 12 paired breast cancer and adjacent tissues identified up-regulated and down-regulated lncRNAs of Basal subtype in contrast to Luminal A, Luminal B and HER2 subtypes. Additionally, Kaplan-Meier analysis revealed that high expression of lncRNA (ZEB1-AS1 and TMEM254-AS1) had a poor relapse-free survival rate (RFS), while high expression of lncRNA (LINC01087, LINC01122 and LINC00856) had a positive correlation with RFS. Furthermore, qRT-PCR analysis showed that the mRNA expressions of the ZEB1-AS1 and TMEM254-AS1 lncRNA were up-regulated in TNBC tissues, while the mRNA expression of lncRNA, including LINC01087, LINC01122 and LINC00856 were down-regulated in TNBC tissues. Taken together, our results elucidated that 5 novel lncRNAs, including ZEB1-AS1, TMEM254-AS1, LINC01087, LINC01122 and LINC00856 contributed to the progression of invasive TNBC. These lncRNAs could be molecular biomarkers for the development of TNBC treatment.
Keywords: TNBC, long noncoding RNA (lncRNA), RNA-sequencing, ZEB1-AS1, TMEM254-AS1, LINC01087, LINC01122, LINC00856.
References
Jiang YZ, Ma D, Suo C, Shi J, Xue M, Hu X, et al. Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment Strategies. Cancer Cell 2019; 35(3): 428-440 e425.
Jiang YZ, Liu YR, Xu XE, Jin X, Hu X, Yu KD, et al. Transcriptome Analysis of Triple-Negative Breast Cancer Reveals an Integrated mRNA-lncRNA Signature with Predictive and Prognostic Value. Cancer Res 2016; 76(8): 2105-2114.https://doi.org/10.1158/0008-5472.CAN-15-3284
de la Mare JA, Contu L, Hunter MC, Moyo B, Sterrenberg JN, Dhanani KC, Mutsvunguma LZ, Edkins AL. Breast cancer: current developments in molecular approaches to diagnosis and treatment. Recent Pat Anticancer Drug Discov 2014; 9(2): 153-75.https://doi.org/10.2174/15748928113086660046
Huang JZ, Chen M, Chen, Gao XC, Zhu S, Huang H, et al. A Peptide Encoded by a Putative lncRNA HOXB-AS3 Suppresses Colon Cancer Growth. Mol Cell 2017; 68(1): 171-184 e176.https://doi.org/10.1016/j.molcel.2017.09.015
Anastasiadou E, Jacob LS, Slack FJ. Non-coding RNA networks in cancer. Nat Rev Cancer 2018; 18(1): 5-18.https://doi.org/10.1038/nrc.2017.99
Niknafs YS, Han S, Ma T, Speers C, Zhang C, Wilder-Romans K, et al. The lncRNA landscape of breast cancer reveals a role for DSCAM-AS1 in breast cancer progression. Nat Commun 2016; 7 12791.https://doi.org/10.1038/ncomms12791
Gupta RA, Shah N, Wang KC, Kim J, Horlings HM, Wong DJ, et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 2010; 464 (7291): 1071-1076.https://doi.org/10.1038/nature08975
Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 2010; 26(1): 139-140.https://doi.org/10.1093/bioinformatics/btp616
Soneson C, Delorenzi M. A comparison of methods for differential expression analysis of RNA-seq data. BMC Bioinformatics 2013; 14: 91.https://doi.org/10.1186/1471-2105-14-91
Liu K, Gao L, Ma X, Huang JJ, Chen J, Zeng L, et al. Long non-coding RNAs regulate drug resistance in cancer. Mol Cancer 2020; 19(1): 54.https://doi.org/10.1186/s12943-020-01162-0
Moens S, Zhao P, Baietti MF, Marinelli O, Van Haver D, Impens F, et al. The mitotic checkpoint is a targetable vulnerability of carboplatin-resistant triple negative breast cancers. Sci Rep 2021; 11(1): 3176.https://doi.org/10.1038/s41598-021-82780-6
Li T, Xie J, Shen C, Cheng D, Shi Y, Wu Z, et al. Upre-gulation of long noncoding RNA ZEB1-AS1 promotes tumor metastasis and predicts poor prognosis in hepatocellular carcinoma. Oncogene 2016; 35(12): 1575-1584.https://doi.org/10.1038/onc.2015.223
Su W, Xu M, Chen X, Chen N, Gong J, Nie L, et al. Long noncoding RNA ZEB1-AS1 epigenetically regulates the expressions of ZEB1 and downstream molecules in prostate cancer. Mol Cancer 2017; 16(1): 142.https://doi.org/10.1186/s12943-017-0711-y
Lv QL, Hu L, Chen SH, Sun B, Fu ML, Qin CZ, et al. A Long Noncoding RNA ZEB1-AS1 Promotes Tumorigenesis and Predicts Poor Prognosis in Glioma. Int J Mol Sci 2016; 17(9).https://doi.org/10.3390/ijms17091431
Shaath H, Vishnubalaji R, Elango R, Khattak S, Alajez N.M Single-cell long noncoding RNA (lncRNA) transcriptome implicates MALAT1 in triple-negative breast cancer (TNBC) resistance to neoadjuvant chemotherapy. Cell Death Discov 2021; 7(1): 23.https://doi.org/10.1038/s41420-020-00383-y
De Palma FDE, Del Monaco V, Pol JG, Kremer M, D'Argenio V, Stoll G, et al. The abundance of the long intergenic non-coding RNA 01087 differentiates between luminal and triple-negative breast cancers and predicts patient outcome. Pharmacol Res 2020; 161: 105249
Downloads
Published
Issue
Section
How to Cite
Similar Articles
- Teoh Han Pinn, Siti Fathiah Masre, Nadiah Abu, MiR-130b-3p Suppress the Migration, Proliferation and Chemosensitization of Hepatocellular Carcinoma Cells , Journal of Cancer Research Updates: Vol. 13 (2024)
- Hossein Mozdarani, Zainab Kouchak Mashkdouz, The Potent Regulatory Role of Circular RNAs in Breast Cancer Development, Diagnosis and Treatment: An Update , Journal of Cancer Research Updates: Vol. 11 (2022)
- Kamal Asadipour, Narendra Banerjee, Jazmine Cuffee, Karrington Perry, Shennel Brown, Anasua Banerjee, Erik Armstrong, Stephen Beebe, Hirendra Banerjee, Studying the Role of Novel Carbon Nano Tubes as a Therapeutic Agent to Treat Triple Negative Breast Cancer (TNBC) - an In Vitro and In Vivo Study , Journal of Cancer Research Updates: Vol. 13 (2024)
- Raafat S. Alameddine, Nagi S. El Saghir, Elias Elias, Ahmad Saleh, Fady B. Geara, Sally Temraz, Ali Shamseddine, Effects of Nodal Status and Extent of Surgery on Survival in Triple Negative Breast Cancer , Journal of Cancer Research Updates: Vol. 2 No. 4 (2013)
- Hirendra Banerjee, Jamel Joyner, Monet Stevenson, William Kahan, Christopher Krauss, Sasha Hodges, Eduardo Santos, Myla Worthington, Jeffferey Rousch, Gloria Payne, Vinod Manglik, Narendra Banerjee, Brianna Morris, Dayton Bell, Santosh Mandal, Short Communication: Studying the Role of Smart Flare Gold Nano Particles in Studying Micro RNA and Oncogene Differential Expression in Prostate Cancer Cell Lines , Journal of Cancer Research Updates: Vol. 6 No. 2 (2017)
- N. Aygun, O. Altungoz, Novel Structural Abnormalities Involving Chromosomes 1, 17 and 2 Identified by Fluorescence In Situ Hybridization (FISH) and/or Cytogenetic Karyotyping in Kelly and SH-SY5Y Human Neuroblastoma Cell Lines, Respectively , Journal of Cancer Research Updates: Vol. 6 No. 3 (2017)
- Yujiro Naruse, Surface Functionalization of Gold Nanoparticles for Simultaneous Suppression of Cancer Stem Cells and Cancer Cells , Journal of Cancer Research Updates: Vol. 3 No. 3 (2014)
- Fatma Gharib, Rana Ali El Falah, Amr S. Ghobara, Sherehan Moeness ElShishtawy, Radwa A. Awad, Hypofractionated Versus Conventional Fractionated Radiotherapy for Patients with Triple Negative Breast Cancer: A Single Institution Randomized Trial , Journal of Cancer Research Updates: Vol. 14 (2025)
- Wifaq Siam, Mona Ellaithi, Hind M. AbuShama, Abdulrahman Mujalli, Shakir Idris, Alaa Siddiq, Osama Mohamed Khair, Dania A. Albader, Faris M. Elmahdi, Clinicopathological Features and RB1 Gene Polymorphism in Sudanese Retinoblastoma Patients , Journal of Cancer Research Updates: Vol. 14 (2025)
- Lei Xu, Jonathan Shamash, Yong-Jie Lu, Circulating Tumor Cells: A Window to Understand Cancer Metastasis, Monitor and Fight Against Cancers , Journal of Cancer Research Updates: Vol. 4 No. 1 (2015)
You may also start an advanced similarity search for this article.